what’s new with her2-neu inhibition
Published 7 years ago • 286 plays • Length 4:10Download video MP4
Download video MP3
Similar videos
-
4:19
asco: new treatment (t-dm1) for her2-positive advanced breast cancer?
-
3:16
dual her2 blockade defers breast cancer in cleopatra
-
4:06
her2 patients may do fine with local therapies alone
-
6:13
cleopatra: success with dual her2 blockade in breast cancer
-
3:00
genes may predict trastuzumab outcomes in breast cancer
-
3:11
her2-positive breast cancer
-
36:45
decoding her2 in nsclc: advances in biomarker testing and targeted therapies
-
13:09
get all the info you need about her2 ve breast cancer - her2 ve breast cancer || dr liz o'riordan
-
3:07
breast cancer drug t-dm1 shows promise in trial
-
2:02
katherine trial: t-dm1 cuts her2-positve invasive breast cancer recurrence
-
37:55
her2/neu breast ca | dr. tony talebi discusses the treatment of stage i-iii her2/neu breast cancer.
-
0:56
revolutionizing her2-positive breast cancer treatment: unveiling breakthrough results!
-
0:55
neoadjuvant treatment approach for her2 positive breast cancer
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
1:54
her2 positive metastatic breast cancer treatment options explained
-
4:12
cdk4/6, et, lhrh combo improves pfs in premenopausal breast cancer
-
3:58
breast cancer treatment nyc | her2 positive breast cancer | weill cornell breast center
-
4:17
ctc matches md judgment for mbc therapeutic choice
-
2:54
panacea trial and implications for pembrolizumab use in breast cancer
-
2:57
circulating tumor cells may identify asymptomatic late breast cancer recurrences
-
9:17
san antonio roundtable, part 3: trastuzumab, bevacizumab, and angiogenesis inhibitors
-
3:38
treating early breast cancer